Nimmagadda Prasad

Nimmagadda Prasad is the Founder of Matrix Laboratories, a pharmaceutical company based in Hyderabad, India. With his dynamic entrepreneurial initiatives, Prasad transformed Matrix into one of India’s major pharmaceutical companies. Matrix is now a part of Mylan, the world’s third-largest generic pharmaceutical company. Matrix launched “Project Hope” in 2003 to develop cost-effective medicines for HIV/AIDS treatment. Matrix signed two historic agreements with the Clinton Foundation through their Clinton HIV/AIDS Initiative (CHAI). Matrix currently provides medication to about 35% of HIV/AIDS patients in the developing world. Prasad created and funded the Nimmagadda Foundation to support institutions that work in facilitating healthcare, education, and empowerment. He serves on the Executive Board of the Indian School of Business (ISB).